CANY
NGM

Caxton Associates (New York)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Caxton Associates (New York)’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,352
Closed -$83.8K – 631
2023
Q2 		$83.8K Sell
32,352
-9,262
-22% -$24K 0.01% 458
2023
Q1 		$170K Buy
+41,614
New +$170K 0.03% 430